News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,221 Results
Type
Article (11756)
Company Profile (75)
Press Release (266390)
Section
Business (90814)
Career Advice (735)
Deals (15930)
Drug Delivery (58)
Drug Development (21033)
Employer Resources (41)
FDA (5787)
Job Trends (7029)
News (137291)
Policy (13420)
Tag
Academia (1153)
Alliances (26726)
Alzheimer's disease (446)
Approvals (5785)
Artificial intelligence (99)
Bankruptcy (122)
Best Places to Work (5983)
Biosimilars (64)
Breast cancer (85)
Cancer (660)
Career advice (615)
Cell therapy (143)
Clinical research (16957)
Collaboration (345)
Compensation (220)
COVID-19 (1010)
C-suite (66)
Data (558)
Diabetes (55)
Diagnostics (3476)
Drug pricing (69)
Earnings (30830)
Events (33769)
Executive appointments (271)
FDA (6216)
Funding (248)
Gene therapy (109)
GLP-1 (196)
Government (2504)
Healthcare (9760)
Infectious disease (1066)
Inflammatory bowel disease (54)
Interviews (112)
IPO (6791)
Job creations (1230)
Job search strategy (533)
Layoffs (120)
Legal (2373)
Lung cancer (103)
Manufacturing (167)
Medical device (5749)
Medtech (5752)
Mergers & acquisitions (9360)
Metabolic disorders (127)
Neuroscience (552)
NextGen: Class of 2025 (3558)
Non-profit (2568)
Northern California (774)
Obesity (48)
Opinion (77)
People (26664)
Phase I (5257)
Phase II (7126)
Phase III (6105)
Pipeline (348)
Policy (72)
Postmarket research (618)
Preclinical (2061)
Press Release (71)
Radiopharmaceuticals (93)
Rare diseases (101)
Real estate (3586)
Regulatory (9384)
Research institute (1060)
Resumes & cover letters (107)
Southern California (715)
Startups (1377)
United States (7549)
Vaccines (217)
Date
Last 7 days (252)
Last 30 days (1035)
Last 365 days (14365)
2025 (1942)
2024 (14633)
2023 (16700)
2022 (23982)
2021 (25337)
2020 (25304)
2019 (23983)
2018 (18171)
2017 (13655)
2016 (13153)
2015 (14730)
2014 (10513)
2013 (8804)
2012 (9579)
2011 (10155)
2010 (8710)
Location
Africa (301)
Arizona (67)
Asia (15640)
Australia (1985)
California (1810)
Canada (910)
China (196)
Colorado (114)
Connecticut (87)
Delaware (50)
Europe (36192)
Florida (283)
Georgia (60)
Illinois (241)
Indiana (100)
Japan (52)
Maryland (409)
Massachusetts (1257)
Michigan (91)
Minnesota (121)
New Jersey (630)
New York (488)
North Carolina (480)
Northern California (774)
Ohio (100)
Pennsylvania (477)
South America (474)
Southern California (715)
Texas (288)
Utah (49)
Washington State (150)
278,221 Results for "scorpion biological services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Lilly Drops Up to $2.5B for Scorpion’s PI3K-inhibitor Molecule
The multi-billion deal, in which Eli Lilly will acquire Scorpion Therapeutics’ STX-478 program, is a shot in the arm for PI3K treatments, which have had a mixed history over the past few years.
January 13, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program
January 14, 2025
·
6 min read
Press Releases
Scorpion Therapeutics Provides Clinical Program Updates for Its Mutant-Selective PI3Kα Inhibitor STX-478
December 10, 2024
·
6 min read
Lone Star Bio
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Scorpion Biological Services announced it has changed its name to Scorpius BioManufacturing reflecting the company’s recently expanded manufacturing capabilities and the grand opening of its new biomanufacturing facility in San Antonio in October.
December 20, 2022
·
2 min read
Press Releases
Biological Safety Testing Services Market Size to Hit USD 10.82 Billion by 2034
February 18, 2025
·
1 min read
Business
Scorpion Biological Services Celebrates Grand Opening of its San Antonio Facility
Scorpion Biological Services, a fully integrated contract research and contract development & manufacturing organization focused on the development of biologic drugs, hosted the grand opening of its new, state-of-the-art San Antonio facility on Friday, October 21, 2022.
October 25, 2022
·
2 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Business
Scorpion Therapeutics Appoints Precision Medicine Leader Jeff Albers as Strategic Advisor
Scorpion Therapeutics, Inc. today announced the appointment of Jeff Albers as a strategic advisor to the company.
October 24, 2023
·
3 min read
Business
Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D., as Chief Executive Officer and Expands Leadership Team
Scorpion Therapeutics, Inc. announced leadership changes intended to position the Company for its next phase of growth, including the appointment of Adam Friedman, M.D., Ph.D., as Chief Executive Officer.
January 4, 2024
·
7 min read
Business
NightHawk Biosciences Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer of Scorpion Biological Services
NightHawk Biosciences announced the appointment of Stephan Kutzer, Ph.D. as Interim Chief Executive Officer of Scorpion Biological Services.
June 13, 2022
·
5 min read
1 of 27,823
Next
